Business Context and Reporting Period
Company: Organigram Holdings Inc. (Foreign Private Issuer)
Filing Type: Form 6-K
Reporting Period: March 2025 (Specifically March 26, 2025)
Principal Executive Offices: 145 King Street West, Suite 1400, Toronto, Ontario, Canada
This filing serves as a report of current events pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The filing text provided does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing discloses the submission of two key exhibits indicating corporate actions:
- Exhibit 99.1: A news release dated March 26, 2025.
- Exhibit 99.2: Articles of Amendment dated March 24, 2025.
The filing text itself does not detail the specific content of the news release or the nature of the amendments contained in the Articles of Amendment.
Guidance, Outlook, and Risks
The provided text does not include management commentary, financial guidance, outlook statements, risk factors, contingencies, or descriptions of unusual items. These details are likely contained within the referenced exhibits (99.1 and 99.2) which are not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (News Release) to understand the specific corporate announcement made on March 26, 2025.
- Examine Exhibit 99.2 (Articles of Amendment) to determine the specific changes to the company's charter or bylaws approved on March 24, 2025.
- Verify if the Articles of Amendment impact share capital structure, voting rights, or corporate governance.
- Check subsequent filings for financial impact related to the events disclosed in this 6-K.